The DOI matches its Crossref record.
Patterns of synthetic cannabinoid use in Australia
Open accessAbstract
Introduction and Aims: To assess the demographic profile, use patterns, market characteristics, reasons for first use and self‐reported harms associated with use of synthetic cannabinoids in A ustralia. Design and Methods: An online questionnaire was administered to a purposive sample of 316 Australian synthetic cannabinoid users [96% cannabis users, 77% male, median age 27 years, interquartile range (IQR) 23–34] who self‐reported demographic and drug use characteristics. Results: The median duration of synthetic cannabinoid use was 6 months (IQR 2–10), 35% reported use weekly or more often and 7% reported daily use. Reasons for first use included curiosity (50%), legality (39%), availability (23%), recreational effects (20%), therapeutic effects (9%), non‐detection in standard drug screening assays (8%) and to aid the reduction or cessation of cannabis use (5%). Users reported buying a median of 3 g (IQR 3–6) and paying a median of AU$60 (IQR 37–90). Most (68%) reported at least one side‐effect during their last session of use, including decreased motor co‐ordination (39%), fast or irregular heartbeat (33%), dissociation (22%), dizziness (20%), paranoia (18%) and psychosis (4%). 4 respondents reported seeking help. A greater number of side‐effects were reported by males, those aged 18–25 years, water pipe (‘bong’) users and concurrent alcohol drinkers. Discussion and Conclusions: The sample reported first using synthetic cannabinoids due to curiosity, legality, availability, effects, non‐detection in drug testing and to reduce their cannabis use. Harms were widely reported yet help‐seeking was minimal. Inclusion of questions regarding synthetic cannabinoids in household surveys is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
Castaneto, M. S., Gorelick, D. A., Desrosiers, N. A., Hartman, R. L., Pirard, S., & Huestis, M. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.08.005 · Cited by 709
“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Adams, A. J., Banister, S. D., Irizarry, L., Trecki, J., Schwartz, M., & Gerona, R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610300 · Cited by 320
Spicing things up: synthetic cannabinoids
Spaderna, M., Addy, P. H., & D’Souza, D. C. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3188-4 · Cited by 296
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
van Amsterdam, J., Brunt, T., & van den Brink, W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565142 · Cited by 244
Orsolini, L., Francesconi, G., Papanti, D., Giorgetti, A., & Schifano, F. (2015) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2466 · Cited by 70
Metadata
- Authors
- Barratt, M. J., Cakic, V., & Lenton, S.
- Venue
- Drug and Alcohol Review
- Publisher
- Wiley
- Published
- 2012-10-09
- Volume
- 32
- Issue
- 2
- Pages
- 141-146
- ISSN
- 0959-5236 (ISSN-L)
- 1465-3362
- OpenAlex
- W1868149644
- Cited by
- 219
- References
- 0
- FWCI
- 19.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Patterns of synthetic cannabinoid use in Australia. https://app.cochat.ai/papers/10.1111/j.1465-3362.2012.00519.x
- The paper
- Barratt, M. J., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review. https://doi.org/10.1111/j.1465-3362.2012.00519.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.